Inflammation and Cancer: Triggers, Mechanisms, and Consequences

Greten, Florian R., Grivennikov, Sergei I.·2019·Immunity
DOI 10.1016/j.immuni.2019.06.025

Cited by (1,001)

Items 701–800 of 1,001

  1. Genetic variations in the CTLA-4 immune checkpoint pathway are associated with colon cancer risk, prognosis, and immune infiltration via regulation of IQCB1 expression
    Shuai Ben, Qiuyuan Zhu, Silu Chen, Shuwei Li, Mulong Du, Junyi Xin, Haiyan Chu, Zhengdong Zhang, Meilin Wang · 2021 · Archives of Toxicology
  2. Periodontal pathogens and cancer development
    Yuxi Zhou, Joerg Meyle, Sabine Elisabeth. Groeger · 2024 · Periodontology 2000
  3. Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters
    Hyung Bae Park, Ki Hyun Kim, Ju Hwan Kim, Sang Il Kim, Yu Mi Oh, Miseung Kang, Seoho Lee, Siwon Hwang, Hyeonmin Lee, TaeJin Lee et al. · 2024 · Nature Communications
  4. The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
    Liuyue Kan, Yingyan Yu, Yaxue Wang, Lei Shi, Tingyuan Fan, Hui Chen, Chuanli Ren · 2025 · Molecular Cancer
  5. Papillary thyroid carcinoma with Hashimoto’s thyroiditis: impact and correlation
    Shiwei Yao, Hong Zhang · 2025 · Frontiers in Endocrinology
  6. MicroRNA binding site polymorphism in inflammatory genes associated with colorectal cancer: literature review and bioinformatics analysis
    Mohammad Reza Karimzadeh, Maryam Zarin, Naeim Ehtesham, Sharifeh Khosravi, Mohsen Soosanabadi, Meysam Mosallaei, Peyman Pourdavoud · 2020 · Cancer Gene Therapy
  7. Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance
    Chao-Yuan Weng, Cheng-Xiang Kao, Te‐Sheng Chang, Yen‐Hua Huang · 2021 · International Journal of Molecular Sciences
  8. Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors
    Jacqueline Theresa Brown, Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Elise Hitron, Greta Anne Russler, Sarah E. Caulfield, Lauren Beth Yantorni, Shreyas Subhash Joshi et al. · 2021 · The Oncologist
  9. Phytochemical Screening, Toxicity Activity and Antioxidant Capacity of Ethanolic Extract of Etlingera alba Rhizome
    Wahyuni Wahyuni, Ajeng Diantini, Mohammad Ghozali, Anas Subarnas, Euis Julaeha, Riezki Amalia, Idin Sahidin · 2021 · Pakistan Journal of Biological Sciences
  10. Endothelial Reprogramming Stimulated by Oncostatin M Promotes Inflammation and Tumorigenesis in VHL -Deficient Kidney Tissue
    Hieu-Huy Nguyen-Tran, Thi-Ngoc Nguyen, Chen-Yun Chen, Tien Hsu · 2021 · Cancer Research
  11. Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios As Predictors of Outcomes in Inflammatory Breast Cancer
    Ouissam Al Jarroudi, Khalid El Bairi, Naïma Abda, Adil Zaimi, Laila Jaouani, Hind Chibani, Saïd Afqir · 2021 · Biomarkers in Medicine
  12. Eicosanoid regulation of debris-stimulated metastasis
    Jianjun Deng, Haixia Yang, Victoria M. Haak, Jun Yang, Franciele Cristina Kipper, Chantal Barksdale, Sung Hee Hwang, Allison Gartung, Diane Renee Bielenberg, Selvakumar Subbian et al. · 2021 · Proceedings of the National Academy of Sciences
  13. Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
    Khalid El Bairi, Ouissam Al Jarroudi, Saïd Afqir · 2021 · Frontiers in Oncology
  14. Anticancer and Anti-Inflammatory Effects of Tomentosin: Cellular and Molecular Mechanisms
    Nasreddine El Omari, Naoual El Menyiy, Gökhan Zengin, Bey Hing Goh, Monica Gallo, Domenico Montesano, Daniele Naviglio, Abdelhakim Bouyahya · 2021 · Separations
  15. Targeting Tumour-Associated Fibroblasts in Cancers
    Kairav Shah, Sanchari Basu Mallik, Praveer K. Gupta, Abishek Iyer · 2022 · Frontiers in Oncology
  16. Noninvasive Diagnosis of Nasopharyngeal Carcinoma Based on Phenotypic Profiling of Viral and Tumor Markers on Plasma Extracellular Vesicles
    Yunyun Hu, Ye Tian, Haonan Di, Chengfeng Xue, Yanping Zheng, Bin Hu, Qin Lin, Xiaomei Yan · 2022 · Analytical Chemistry
  17. Mesenchymal Stem Cell-Derived Antimicrobial Peptides as Potential Anti-Neoplastic Agents: New Insight into Anticancer Mechanisms of Stem Cells and Exosomes
    Kasra Moeinabadi‐Bidgoli, Malihe Rezaee, Hamidreza Rismanchi, Mohaddese Malek Mohammadi, Amirhesam Babajani · 2022 · Frontiers in Cell and Developmental Biology
  18. Peripheral blood lymphocyte subsets are associated with the clinical outcomes of prostate cancer patients
    Fei Mao, Chao Yang, Weiyu Luo, Yijin Wang, Jie Xie, Hengbing Wang · 2022 · International Immunopharmacology
  19. Atomic vacancies-engineered ultrathin trimetallic nanozyme with anti-inflammation and antitumor performances for intestinal disease treatment
    Yachao Wang, Xinyue Dai, Lina Wu, Huijing Xiang, Yu Chen, Ruifang Zhang · 2023 · Biomaterials
  20. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer
    Behnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, Farhad Jadidi‐Niaragh, Jamshid Hadjati, Christine E. Brown, Hamid Reza Mirzaei · 2023 · Frontiers in Immunology
  21. Serpin Family A Member 1 Is Prognostic and Involved in Immunological Regulation in Human Cancers
    Xingwang Kuai, Jiaying Lv, Junyu Zhang, Manyu Xu, Juling Ji · 2023 · International Journal of Molecular Sciences
  22. Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
    Morten Orebo Holmström, Hans Carl Hasselbalch, Mads Hald Andersen · 2020 · Cancers
  23. Assessment of systemic immune-inflammation index in predicting postoperative pulmonary complications in patients undergoing lung cancer resection
    Xiaowei Mao, Zhang Jian Wei, Qiang Wang, Yiqian Ni, Yanjie Niu, Liyan Jiang · 2022 · Surgery
  24. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment
    Yi Liu, Daoyan Wei, Yasunori Deguchi, Weiguo Xu, Rui Tian, Fuyao Liu, Min Xu, Fei Mao, Donghui Li, Weidong Chen et al. · 2023 · Gastric Cancer
  25. Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment
    Ali Attiq, Sheryar Afzal · 2023 · Frontiers in Pharmacology
  26. S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy
    Farnaz Razmkhah, Sena Kim, Sora Lim, Abdul-Jalil Dania, Jaebok Choi · 2023 · International Journal of Molecular Sciences
  27. Benzoindolizidine Alkaloids Tylophorine and Lycorine and Their Analogues with Antiviral, Anti-Inflammatory, and Anticancer Properties: Promises and Challenges
    Antonella Di Sotto, Mehdi Valipour, Aala Azari, Silvia Di Giacomo, Hamid Irannejad · 2023 · Biomedicines
  28. Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma
    Jiao Zhou, Sheng Wei, Xiumei Guo, Yanjun Huang, Yizheng Zhang, Yuming Hong, Xiaofang Chen, Ming Lu, Feng Zheng, Chao‐Hui Zheng · 2023 · BMC Cancer
  29. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients
    Fanli Qu, Yaxi Luo, Yang Peng, Haochen Yu, Lu Sun, Shengchun Liu, Xiaohua Zeng · 2024 · Frontiers in Immunology
  30. Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection
    Shichao Zhou, Haihua Yuan, Jiongyi Wang, Xiaohua Hu, Feng Liu, Yanjie Zhang, Bin Jiang, Wenying Zhang · 2020 · Future Oncology
  31. Impact of inflammation and immunotherapy in renal cell carcinoma (Review)
    Jian Shi, Keshan Wang, Zhiyong Xiong, Changfei Yuan, Cheng Wang, Qi Cao, Yu Huang, Xiangui Meng, Kairu Xie, Zhixian Cheng et al. · 2020 · Oncology Letters
  32. Tetrabromobisphenol A induces THR β-mediated inflammation and uterine injury in mice at environmentally relevant exposure concentrations
    Wenjuan Zhang, Aijing Li, Yu Pan, Fengbang Wang, Ming Li, Yong Liang, Xinglei Yao, Jinghai Song, Maoyong Song, Guibin Jiang · 2020 · Journal of Hazardous Materials
  33. Luteolin transforms the polarity of bone marrow-derived macrophages to regulate the cytokine storm
    Shuxia Wang, Shuhang Xu, Jing Zhou, Li Zhang, Xiaodong Mao, Xiaoming Yao, Chao Liu · 2021 · Journal of Inflammation
  34. Colorectal cancer and adjacent normal mucosa differ in apoptotic and inflammatory protein expression
    Xiaojing Sun, Zhonghua Xue, Aqeela Yasin, Yingkun He, Yaru Chai, Jingan Li, Kun Zhang · 2021 · Engineered Regeneration
  35. Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective
    Yoshihiro Hayashi, Yuka Harada, Hironori Harada · 2022 · Leukemia
  36. IL6 and CCL18 Mediate Cross-talk between VHL -Deficient Kidney Cells and Macrophages during Development of Renal Cell Carcinoma
    Thi-Ngoc Nguyen, Hieu-Huy Nguyen-Tran, Chen-Yun Chen, Tien Hsu · 2022 · Cancer Research
  37. Construction of an in vivo NIR fluorescent probe for revealing the correlation between inflammation and mitochondrial hydrogen sulfide and viscosity
    Yali Cui, Guizhen Hu, Tian Wu, Jialu Yang, Yamin Nie, Yanmei Zhou · 2022 · Bioorganic Chemistry
  38. Lifestyle and environmental factors may induce airway and systemic inflammation in firefighters
    Joanna Orysiak, Magdalena Młynarczyk, Robert Piec, Agnieszka A. Jakubiak · 2022 · Environmental Science and Pollution Research
  39. Bioinformatics analyses of combined databases identify shared differentially expressed genes in cancer and autoimmune disease
    Yuan Sui, Shuping Li, Xueqi Fu, Zhizhuang Joe Zhao, Shu Xing · 2023 · Journal of Translational Medicine
  40. Galectin functions in cancer-associated inflammation and thrombosis
    Linus Kruk, Attila Braun, Erika C. Cosset, Thomas W. Gudermann, Elmina Mammadova‐Bach · 2023 · Frontiers in Cardiovascular Medicine
  41. Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
    Xin Qiu, Zhan Shi, Fan Tong, Changchang Lu, Yahui Zhu, Qiao-Li Wang, Qing Gu, Xiaoping Qian, Fanyan Meng, Baorui Liu et al. · 2023 · Human Vaccines & Immunotherapeutics
  42. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer
    Lincoln N. Strickland, Erika Yanil Faraoni, Wei Ruan, Xiaoyi Yuan, Holger K. Eltzschig, Jennifer M. Bailey · 2023 · Frontiers in Immunology
  43. MGREL: A multi-graph representation learning-based ensemble learning method for gene-disease association prediction
    Ziyang Wang, Yaowen Gu, Si Zheng, Lin Yang, Jiao Li · 2023 · Computers in Biology and Medicine
  44. The role of microbiota in esophageal squamous cell carcinoma: A review of the literature
    Hsueh‐Chien Chiang, Michael Warren Hughes, Wei‐Lun Chang · 2023 · Thoracic Cancer
  45. SAA suppresses α-PD-1 induced anti-tumor immunity by driving TH2 polarization in lung adenocarcinoma
    Xin Wang, Shaodi Wen, Xiaoyue Du, Yihan Zhang, Xiao Yang, Renrui Zou, Bing Feng, Xiao Fu, Feng Jiang, Guoren Zhou et al. · 2023 · Cell Death and Disease
  46. Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations
    Aakash Nathani, Li Jun Sun, Islauddin Khan, Mounika Aare, Arvind Bagde, Yan Li, Mandip S. Singh · 2024 · Pharmaceutics
  47. Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)
    Mohammad Mahboubi‐Rabbani, Amir Hossein Abdolghaffari, Mahsa Ghesmati, Ali Amini, Afshin Zarghi · 2024 · Expert Opinion on Therapeutic Patents
  48. The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy
    Guandu Li, Xiangyu Che, Shijin Wang, Dequan Liu, Deqian Xie, Bowen Jiang, Zunwen Zheng, Zheng Xu, Guangzhen Wu · 2025 · Annals of Medicine
  49. Candida Infections: The Role of Saliva in Oral Health—A Narrative Review
    Riyoko Tamai, Yusuke Kiyoura · 2025 · Microorganisms
  50. Prognostic scoring system using inflammation- and nutrition-related biomarkers to predict prognosis in stage I-III colorectal cancer patients
    Ke-Jin Li, Ziyi Zhang, Kuan Wang, Subinur Sulayman, Xiangyue Zeng, Juan Liu, Yi g Chen, Zeliang Zhao · 2025 · World Journal of Gastroenterology
  51. Targeting Redox Signaling Through Exosomal MicroRNA: Insights into Tumor Microenvironment and Precision Oncology
    Moon Nyeo Park, Myoungchan Kim, Soojin Lee, Sojin Kang, Chi‐Hoon Ahn, Trina Ekawati Tallei, Woojin Kim, Bonglee Kim · 2025 · Antioxidants
  52. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro
    Mingyue Duan, Fei Hu, Dan Li, Shouzhen Wu, Niancai Peng · 2020 · Life Sciences
  53. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome
    Fatima Domenica Elisa De Palma, Valentina Del Monaco, Jonathan G. Pol, Margerie Kremer, Valeria D’Argenio, Gautier Stoll, Donatella Montanaro, Barbara Uszczyńska-Ratajczak, Cecília C. Klein, Anna V Vlasova et al. · 2020 · Pharmacological Research
  54. Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The Quest for Striking the Right Balance
    Dana K. Mitchell, Jack M. Shireman, Elizabeth A. Sierra Potchanant, Montserrat A. Lara-Velazquez, Mahua Dey · 2021 · Frontiers in Cellular Neuroscience
  55. Phytochemicals from Polyalthia Species: Potential and Implication on Anti-Oxidant, Anti-Inflammatory, Anti-Cancer, and Chemoprevention Activities
    Yung‐Chia Chen, Yi‐Chen Chia, Bu‐Miin Huang · 2021 · Molecules
  56. The Cellular Prion Protein and the Hallmarks of Cancer
    Sophie Mouillet‐Richard, Alexandre Ghazi, Pierre Laurent‐Puig · 2021 · Cancers
  57. Circular RNAs Modulate Cancer Hallmark and Molecular Pathways to Support Cancer Progression and Metastasis
    Aliaksandr A. Yarmishyn, Afeez Adekunle Ishola, Chieh‐Yu Chen, Nalini Devi Verusingam, Vimalan Rengganaten, Habeebat Aderonke Mustapha, Hao-Kai Chuang, Yuan‐Chi Teng, Van Phung, Po‐Kuei Hsu et al. · 2022 · Cancers
  58. Membrane Vesicles for Nanoencapsulated Sulforaphane Increased Their Anti-Inflammatory Role on an In Vitro Human Macrophage Model
    Lucía Yepes‐Molina, María Isabel Pérez-Jiménez, María Martinez‐Esparza, José A. Teruel, Antonio J. Ruiz‐Alcaraz, Pilar García–Peñarrubia, Micaela Carvajal · 2022 · International Journal of Molecular Sciences
  59. Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX‐2 and PD‐L1
    S. Jin, Muhammad Nafees, Yuewen Sun, Yehong Tan, Hao Yuan, Dongfan Song, Zijian Guo, Xiaoyong Wang · 2020 · Angewandte Chemie
  60. Quinolones as a Potential Drug in Genitourinary Cancer Treatment—A Literature Review
    Tomasz Kloskowski, Sylwia Frąckowiak, Jan Adamowicz, Kamil Szeliski, Marta Rasmus, Tomasz Adam Drewa, Marta Pokrywczyńska · 2022 · Frontiers in Oncology
  61. Overcoming Immunosuppression and Pro-Tumor Inflammation in Lung Cancer with Combined IL-1β and PD-1 Inhibition
    Jay M. Lee, Masahiro Tsuboi, Edward S. Kim, Tony S.K. Mok, Pilar Garrido · 2022 · Future Oncology
  62. Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases
    Zhengyu Fang, Jie Fang, Chunxiao Gao, Rui Gao, Peihong Lin, Wen-Ying Yu · 2022 · Drug Delivery
  63. Thyroidal and Extrathyroidal Requirements for Iodine and Selenium: A Combined Evolutionary and (Patho)Physiological Approach
    Janneke Dijck-Brouwer, Frits A.J. Muskiet, Richard H. Verheesen, G. Schaafsma, Anne Schaafsma, Jan M.W. Geurts · 2022 · Nutrients
  64. Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
    Wanying Shen, Yujie Chen, Lei Pan, Marisela Sheldon, Yutong Sun, Fan Yao, Li Ma · 2022 · Cancers
  65. Natural biomolecules and derivatives as anticancer immunomodulatory agents
    Stavroula Bernitsa, Rotem Dayan, Anastasis Stephanou, Iva D. Tzvetanova, Ioannis S. Patrikios · 2023 · Frontiers in Immunology
  66. Bioactive glass ions hydrogels with antiinflammation antioxidant capacity for treating inflammation-related diseases
    Wenguang Liu, Mi Chen, Meng Luo, Ting Li, Chaoyan Hu, Chenxi Xie, Sihua Li, Tongtong Leng, Tian Jing, Peng Xu et al. · 2023 · Materials & Design
  67. Immunotherapies against HER2-Positive Breast Cancer
    Santiago Duro‐Sánchez, Macarena Román Alonso, Joaquı́n Arribas · 2023 · Cancers
  68. The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
    Kohlhepp, Marlene Sophia, Liu, Hanyang, Tacke, Frank, Guillot, Adrien · 2023 · Frontiers in Molecular Biosciences
  69. Reduced smooth muscle-fibroblasts transformation potentially decreases intestinal wound healing and colitis-associated cancer in ageing mice
    Yi Liu, Yanhong Ji, Ruiyi Jiang, Chao Fang, Gang Shi, Lin Cheng, Yinan Zuo, Yixin Ye, Xiaolan Su, Junshu Li et al. · 2023 · Signal Transduction and Targeted Therapy
  70. The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma
    Kang Li, Xianhai Zeng, Peng Liu, Xiaoxia Zeng, Jie Lv, Shuqi Qiu, Peng Zhang · 2023 · Journal of Inflammation Research
  71. Anticancer potential of garlic bioactive constituents: Allicin, Z-ajoene, and organosulfur compounds
    Wamidh H. Talib, Sally Atawneh, Areen Nabil Shakhatreh, Ghyda’a Nabil Shakhatreh, Islam Subhi Rasheed aljarrah, Reem Ali Hamed, Doaa Adel banyyounes, Intisar Hadi Al-Yasari · 2024 · Pharmacia
  72. The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy
    Shiyu Zhang, Jiajia Du, Xin Zhong, Ping Tan, Hang Xu, Jiapeng Zhang, Di Jin, Yifan Li, Weizhen Le, Xingyu Xiong et al. · 2022 · Frontiers in Immunology
  73. cGAS-STING at the crossroads in cancer therapy
    Rui Wang, Aashiq Hussain, Quanquan Guo, Meimei Ma · 2023 · Critical Reviews in Oncology/Hematology
  74. Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy
    Arefeh Zabeti Touchaei, Seyedeh Elham Norollahi, Ali Najafizadeh, Kosar Babaei, Elahe Bakhshalipour, Sogand Vahidi, Ali Akbar Samadani · 2024 · Cancer Cell International
  75. Mast cells: key players in digestive system tumors and their interactions with immune cells
    Feihong Shu, Jie Yu, Youjia Liu, Fang Wang, Guoyou Gou, Min Wen, Chen Luo, Xianmin Lu, Yanxia Hu, Qian Du et al. · 2025 · Cell Death Discovery
  76. Effects of exercise on inflammation in female survivors of nonmetastatic breast cancer: a systematic review and meta-analysis
    Francesco Bettariga, Dennis R. Taaffe, Anita Borsati, Alice Avancini, Sara Pilotto, Stefano Giuseppe Lazzarini, Pedro López, Luca Maestroni, Umberto Crainich, John P. Campbell et al. · 2025 · JNCI Journal of the National Cancer Institute
  77. From Nature to Nanotechnology: The Bioactivities of Mangiferin Explored
    Al-Madhagi, Haitham · 2025 · Nanotechnology, Science and Applications
  78. Diallyl Sulfide-Mediated Modulation of the Fatty Acid Synthase (FASN) Leads to Cancer Cell Death in BaP-Induced Lung Carcinogenesis in Swiss Mice
    Arif Khan, Fahad Abdulrahman Alhumaydhi, Ameen S. S. Alwashmi, Khaled S. Allemailem, Mohammed A. Alsahli, Faris Alrumaihi, Ahmad Almatroudi, Mugahid A. Mobark, Ayman Mousa, Masood Alam Khan · 2020 · Journal of Inflammation Research
  79. Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
    Wenlong Wu, Quancheng Wang, Dandan Han, Jianhui Li, Ye Nie, Dongnan Guo, Long Yang, Kaishan Tao, Xuan Zhang, Dou Ke-feng · 2021 · Cancer Cell International
  80. FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer
    Anyuan Zhong, Ting Chen, Yufei Xing, Xue Pan, Minhua Shi · 2021 · Frontiers in Immunology
  81. Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases
    Weihong Ji, Yan Li, Huan Peng, Ruichen Zhao, Xin Zhang · 2021 · Advanced Drug Delivery Reviews
  82. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer
    Ward Celus, Ana Isabel Oliveira, Silvia Rivis, Heleen H. Van Acker, Ewout Landeloos, Jens Serneels, Sarah Trusso Cafarello, Yannick Van Herck, Roberta Mastrantonio, Arnaud Köhler et al. · 2021 · Cancer Immunology Research
  83. The Complex Network between Inflammation and Colorectal Cancer: A Systematic Review of the Literature
    Rossana Percario, Paolo Panaccio, Fabio F. di Mola, Tommaso Grottola, Pierluigi Di Sebastiano · 2021 · Cancers
  84. A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
    Wen-Yu Zhai, Fangfang Duan, Si Chen, Junye Wang, Yaobin Lin, Yizhi Wang, Bing-Yu Rao, Ze-Rui Zhao, Hao Long · 2022 · Frontiers in Genetics
  85. Decreased CXCR2 expression on circulating monocytes of colorectal cancer impairs recruitment and induces Re-education of tumor-associated macrophages
    Huayang Wang, Qianqian Shao, Jiaoyang Wang, Lei Zhao, Liyang Wang, Zhiqiang Cheng, Congbo Yue, Wendan Chen, Hongchun Wang, Yi Zhang · 2022 · Cancer Letters
  86. Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer
    Shinya Takada, Hidetaka Murooka, Kanae Tahatsu, Maki Yanase, Kengo Umehara, Hirokazu Hashishita, Toru Harabayashi, Satoru Maruyama, Tamotsu Sagawa, Koshi Fujikawa et al. · 2022 · Asian Pacific Journal of Cancer Prevention
  87. Regulatory Roles of Caspase-11 Non-Canonical Inflammasome in Inflammatory Liver Diseases
    Young‐Su Yi · 2022 · International Journal of Molecular Sciences
  88. RETRACTED ARTICLE: Neisseria sicca and Corynebacterium matruchotii inhibited oral squamous cell carcinomas by regulating genome stability
    Xin Shen, Bo Zhang, Xiaoyu Hu, Jia Li, Miaomiao Wu, Caixia Yan, Yutao Yang, Yan Li · 2022 · Bioengineered · Retracted
  89. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer
    Jiannan Xu, Songyao Chen, Jianming Liang, Tengfei Hao, Huabin Wang, Guangyao Liu, Xinghan Jin, Huan Li, Junchang Zhang, Changhua Zhang et al. · 2022 · Frontiers in Immunology
  90. Managing Cancer Drug Resistance from the Perspective of Inflammation
    Shuaijun Lu, Yang Li, Changling Zhu, Weihua Wang, Yuping Zhou · 2022 · Journal of Oncology
  91. Effect of malnutrition as defined by the Global Leadership Initiative on Malnutrition criteria on compliance of adjuvant chemotherapy and relapse-free survival for advanced gastric cancer
    Ryota Matsui, Noriyuki Inaki, Toshikatsu Tsuji · 2022 · Nutrition
  92. Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification
    Poonam Sehgal, Pankaj Chaturvedi · 2023 · Cancers
  93. Emphasis on Adipocyte Transformation: Anti-Inflammatory Agents to Prevent the Development of Cancer-Associated Adipocytes
    Heeju Na, Yaechan Song, Han‐Woong Lee · 2023 · Cancers
  94. A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer
    Gürcan Tunalı, Hamdullah Yanık, Süleyman Can Öztürk, Seçil Demirkol Canlı, Georgios Efthymiou, Kerim Bora Yılmaz, Ellen Van Obberghen‐Schilling, Güneş Esendağlı · 2023 · Breast Cancer Research
  95. The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis
    Leonardo Provenzano, Riccardo Lobefaro, Francesca Ligorio, Emma Zattarin, Luca Zambelli, Caterina Sposetti, Daniele Presti, Giulia Montelatici, Angela Ficchì, Antonia Martinetti et al. · 2023 · Therapeutic Advances in Medical Oncology
  96. The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
    Max Hübner, David Effinger, Ting Wu, Gabriele Strauß, Kristin Pogoda, Friedrich-Wilhelm Kreth, Simone Kreth · 2020 · Cancers
  97. Why Vitamin C Could Be an Excellent Complementary Remedy to Conventional Therapies for Breast Cancer
    Michela Codini · 2020 · International Journal of Molecular Sciences
  98. Discovery of 2H-Indazole-3-carboxamide Derivatives as Novel Potent Prostanoid EP4 Receptor Antagonists for Colorectal Cancer Immunotherapy
    Zhiyuan Cheng, Yijie Wang, Yao Zhang, Chan Zhang, Mengru Wang, Wei Wang, Jiacheng He, Yang Wang, Hankun Zhang, Qiansen Zhang et al. · 2023 · Journal of Medicinal Chemistry
  99. Zinc-Rutin Particles Ameliorate DSS-Induced Acute and Chronic Colitis via Anti-inflammatory and Antioxidant Protection of the Intestinal Epithelial Barrier
    Weisong Wu, Limei Liu, Yingwei Zhu, Jingbin Ni, Jian Lu, Xiaoli Wang, Li Ma, Yanjun Jiang · 2023 · Journal of Agricultural and Food Chemistry
  100. Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study
    Yunxiang Zhou, Xianan Guo, Lu Shen, Kexin Liu, Qunan Sun, Yali Wang, Hui Wang, Wenyu Fu, Yihan Yao, Shijie Wu et al. · 2023 · OncoTargets and Therapy